Form 8-K - Current report:
SEC Accession No. 0001708599-25-000023
Filing Date
2025-03-24
Accepted
2025-03-24 06:37:08
Documents
51
Period of Report
2025-03-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ser-20250324.htm   iXBRL 8-K 25562
2 EX-99.1 ser-20250324xex991xacs2025.htm EX-99.1 8932
3 EX-99.2 march2025-acsdivisionofp.htm EX-99.2 31205
7 march2025-acsdivisionofp001.jpg GRAPHIC 60803
8 march2025-acsdivisionofp002.jpg GRAPHIC 65623
9 march2025-acsdivisionofp003.jpg GRAPHIC 246554
10 march2025-acsdivisionofp004.jpg GRAPHIC 77231
11 march2025-acsdivisionofp005.jpg GRAPHIC 152422
12 march2025-acsdivisionofp006.jpg GRAPHIC 70258
13 march2025-acsdivisionofp007.jpg GRAPHIC 141505
14 march2025-acsdivisionofp008.jpg GRAPHIC 102605
15 march2025-acsdivisionofp009.jpg GRAPHIC 130443
16 march2025-acsdivisionofp010.jpg GRAPHIC 148363
17 march2025-acsdivisionofp011.jpg GRAPHIC 139458
18 march2025-acsdivisionofp012.jpg GRAPHIC 133148
19 march2025-acsdivisionofp013.jpg GRAPHIC 123686
20 march2025-acsdivisionofp014.jpg GRAPHIC 148682
21 march2025-acsdivisionofp015.jpg GRAPHIC 117234
22 march2025-acsdivisionofp016.jpg GRAPHIC 147083
23 march2025-acsdivisionofp017.jpg GRAPHIC 92280
24 march2025-acsdivisionofp018.jpg GRAPHIC 131899
25 march2025-acsdivisionofp019.jpg GRAPHIC 153595
26 march2025-acsdivisionofp020.jpg GRAPHIC 125759
27 march2025-acsdivisionofp021.jpg GRAPHIC 154224
28 march2025-acsdivisionofp022.jpg GRAPHIC 143831
29 march2025-acsdivisionofp023.jpg GRAPHIC 108271
30 march2025-acsdivisionofp024.jpg GRAPHIC 98677
31 march2025-acsdivisionofp025.jpg GRAPHIC 88752
32 march2025-acsdivisionofp026.jpg GRAPHIC 83327
33 march2025-acsdivisionofp027.jpg GRAPHIC 164809
34 march2025-acsdivisionofp028.jpg GRAPHIC 88757
35 march2025-acsdivisionofp029.jpg GRAPHIC 104302
36 march2025-acsdivisionofp030.jpg GRAPHIC 121144
37 march2025-acsdivisionofp031.jpg GRAPHIC 97865
38 march2025-acsdivisionofp032.jpg GRAPHIC 85851
39 march2025-acsdivisionofp033.jpg GRAPHIC 85871
40 march2025-acsdivisionofp034.jpg GRAPHIC 157703
41 march2025-acsdivisionofp035.jpg GRAPHIC 70289
42 march2025-acsdivisionofp036.jpg GRAPHIC 28674
  Complete submission text file 0001708599-25-000023.txt   6065514

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ser-20250324.xsd EX-101.SCH 1800
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ser-20250324_lab.xml EX-101.LAB 54435
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ser-20250324_pre.xml EX-101.PRE 31811
53 EXTRACTED XBRL INSTANCE DOCUMENT ser-20250324_htm.xml XML 2820
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 25762173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)